POINT: LHRH Agonists vs Ovarian Ablation for Suppression of Ovarian Function in Premenopausal Breast Cancer Patients

Reversible ovarian function suppression using LHRH agonists is the preferred first treatment for most premenopausal breast cancer patients.

Source: CancerNetwork - April 15, 2018 Category: Cancer & Oncology Authors: Gini F. Fleming, MD Padma Rajagopal, MD Tags: Breast Cancer Oncology Journal Source Type: news